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ABSTRACT The European Study of the Epidemiology of Mental Disorders (ESEMeD/MHEDEA 2000) is a new cross-
sectional study investigating the prevalence and the associated factors of mental disorders, as well as their effect on
health-related quality of life and the use of services in six European countries. This paper describes the rationale, methods
and the plan for the analysis of the project.
A total of 22,000 individuals representative of the non-institutionalized population aged 18 and over from Belgium,
France, Germany, Italy, the Netherlands and Spain are being interviewed in their homes. Trained interviewers use a
computer-assisted personal interview (CAPI) including the most recent version of the Composite International Diagnostic
Interview (CIDI, 2000), a well-established epidemiological survey for assessing mental disorders.
This is the first international study using the standardized up-to-date methodology for epidemiological assessment.
Sizeable differences in prevalence, impact and level of need that is met by the health services are expected.
The analysis of these differences should facilitate the monitoring of ongoing mental health reform initiatives in Europe
and provide new research hypotheses.
Key words: cross-sectional survey, disability, mental disorders, mental health services, prevalence
Mental disorders are a major source of disability in industrialized countries. According to the World Health
Organization (WHO), major depression is forecast to be the condition causing the second highest loss in disability-
adjusted life years by the year 2020 (Murray, Lopez and Jamison, 1994). Costs of mental health services are high
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and yet there is evidence that the coverage of mental
health care is insufficient to address current need (Rice
and Miller, 1995). The ESEMeD/MHEDEA 2000
project has been designed to examine the prevalence,
the impact and the patterns of treatment of mental
disorders in European countries. The study is a joint
effort of a number of institutions with the financial
support of the European Commission and
GlaxoSmithKline and the endorsement of the WHO.
The project is included in the WHO World Mental
Health 2000 (WMH200). This paper presents an
overview of project objectives and methods.
Prevalence and burden of mental disorders
Prevalence data obtained both in general population
surveys (Canino, Bird, Shrout, Rubio-Stipec, Bravo,
Martinez, Sesman and Guevara, 1987; Faravelli,
Guerrini Degl’Innocenti and Giardinelli, 1989;
Faravelli, Guerrini, Aiazzi, Incerpi and Pallanti, 1990;
Hwu, Yeh and Chang, 1989; Orn, Newman and Bland,
1988; Robins, Helzer, Weissman, Orvaschel,
Gruenberg, Burke and Regier, 1984; Wells, Golding
and Burnam, 1989) and primary care surveys (Olfson,
Fireman, Weissman, Leon, Sheehan, Kathol, Hoven
and Farber, 1997; Ormel, VonKorff, Ustun, Pini,
Korten and Oldehinkel, 1994; Spitzer, Kroenke,
Linzer, Hahn, Williams, deGruy, Brody and Davies,
1995) have documented that up to a quarter of the
population of Western countries meets criteria for an
anxiety or mood disorder in a given year (Kessler,
McGonagle, Zhao, Nelson, Hughes, Eshleman,
Wittchen and Kendler, 1994). Recent studies have
provided information concerning the magnitude of
these problems in some European countries. However,
data are incomplete and comparability of the studies is
limited. The DEPRES survey (Depression Research in
European Society, 1995), conducted in four European
countries and based on interviews with approximately
78,000 subjects, showed an estimated six-month preva-
lence of 6.9% for major depression and demonstrated
that these disorders place a significant burden on the
community (Lepine, Gastpar, Mendlewicz and Tylee,
1997). However, this study was limited by very a low
response rate and high variability in the sampling
frame across countries. Bijl et al. conducted the
Netherlands Mental Health Survey and Incidence
study (NEMESIS), a national population-based
prospective survey in 1996 using an in-home struc-
tured diagnostic interview (Bijl, Ravelli and van
Zessen, 1998). The results demonstrated a significant
prevalence of mental disorders in the Netherlands
(lifetime: 41%; 12-months: 23%). 
It has been noted that the high-prevalence esti-
mates of mental disorders may not be very informative
because many of the community cases may have self-
limiting conditions (Orn, Newman and Bland, 1988).
However, few studies have addressed this issue (Bijl
and Ravelli, 2000a; Jenkins, Lewis, Bebbington,
Brugha, Farrell, Gill and Meltzer, 1997) because they
have not included detailed questions about the level of
severity or impairment.
Factors associated with mental disorders
There is general interest in understanding social and
biological risk factors associated with disease. A
number of social factors appear to play a critical role in
the development and response to symptoms of mental
illness, including family and community dynamics and
stress and cultural factors (Alderete, Vega, Kolody and
Aguilar-Gaxiola, 2000). There is great interest in
documenting secular changes in society that could
help account for these changes. Probable contributing
factors include increases in geographic mobility, the
decline in the nuclear family, and the decline in reli-
giosity. Recent research in several countries has
documented that interpersonal problems are among
the most important adverse consequences of early-
onset psychiatric disorders. People with early onset
disorders in other countries have been shown to have
higher rates of premature sexual activity, early
marriage, marital instability, and relationship violence.
Burden of mental disorders
A number of recent studies suggested that the effects of
mental disorders on quality of life (especially social
role functioning) are enormous. Bijl and Ravelli
(2000a) reported that mood disorders were associated
with poor levels of vitality and social functioning. The
study suggested that comorbidity strongly aggravated
disability. The disability associated with the high
prevalence of mental disorders appear to contribute
about the 15% of the disability adjusted years of life
(DALYs) lost in the developed world (US Department
of Health and Human Services, 1999). Detailed data
about the impact of mental disorders in the general
population are still scarce, however. 
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Use of services for mental disorders
One of the most pressing health-policy issues in all
industrialized countries is how to provide access to
high-quality mental healthcare to people with
emotional problems (US Department of Health and
Human Services Agency for Health Care Policy and
Research, 1993; World Health Organization (WHO),
2000). Several population-based regional and national
studies in the US during the mid 1980s and early 1990s
showed that most people with psychiatric problems do
not receive professional help (Katz, Kessler, Frank,
Leaf, Lin and Edlund, 1997b; Kessler, Frank, Edlund,
Katz, Lin and Leaf, 1997; Regier, Narrow, Rae,
Manderscheid, Locke and Goodwin, 1993).
Furthermore, among those who did access the formal
care system, there were low rates of evidence-based
active treatment, defined by a combination of number
of visits and self-reported use of appropriate medica-
tions (Katz, Kessler, Lin and Wells, 1998).
Valid and comparable population-based informa-
tion in other developed countries about use of mental
healthcare services for different need groups is limited.
Most developed countries have not conducted nation-
al or regional surveys that have addressed services use,
access to care, and unmet need. However, there have
been several exceptions. The DEPRES survey showed
that only a quarter of the subjects with a severe major
depressive episode received antidepressants. Another
important exception was the Ontario Mental Health
Supplement (OMHS) to the 1990 Ontario Health
Survey and the National Comorbidity Survey (NCS).
This showed that, although there were marked differ-
ences in patterns and correlates of services use in
Ontario compared to the US, underuse of services for
those with mental disorders, disability, and distress
was apparent in both regions (Bland, Newman and
Orn, 1997; Katz, Kessler et al., 1997b; Katz, Kessler,
Frank, Leaf and Lin, 1997a; Katz, Kessler et al., 1998;
Kessler, Frank et al., 1997; Olfson, Kessler, Berglund
and Lin, 1998; Parikh, Lin and Lesage, 1997).
Although differences in provider categories and field
dates between the North American surveys and
NEMESIS limit direct comparison of services use, two
publications that addressed comparative services use
suggested that the Netherlands has a pattern of
use more similar to Ontario, Canada than the US
(Alegria, Bijl, Lin, Walters, Kessler, 2000; Bijl and
Ravelli, 2000b).
Against this background, the ESEMeD/MHEDEA-
2000 project was launched to investigate the issues
mentioned above at the European level. Data are being
collected as this manuscript is being prepared. In what
follows, the project objectives and methods are briefly
described. Details on the specific methods of the
project protocol are available at the project public
Web page (www.esemed.org).
Objectives
The ESEMeD/MHEDEA 2000 project has four main
objectives: 
• To estimate and compare across selected European
countries the one-month, 12-month and lifetime
prevalence of the most common mental disorders
in the general population. The disorders included
are: anxiety disorders (generalized anxiety disor-
der, panic disorder, simple phobia, social phobia,
agoraphobia, obsessive compulsive disorder, post-
traumatic stress disorder and separation anxiety
disorder), mood disorders (major depression,
dysthymia, premenstrual dysphoric syndrome) and
other disorders (attention deficit, conduct disor-
der, hyperactivity disorder, oppositional-defiant
disorder, substance use disorders, eating disorders,
and personality disorders).
• To assess and compare, across selected European
countries, the independent association of mood
and anxiety disorders with sociodemographic
factors (gender, age, education, and urban/rural
location) and selected risk factors (including family
history, ethnicity, childhood experiences, religion,
partnership status, and sexual problems, among
others).
• To assess and compare, across selected European
countries, the quality of life (disabilities and gener-
al health perceptions) of persons with different
mood and anxiety disorders and to analyse how
other variables (such as physical medical condi-
tions and sociodemographic factors) may influence
these outcomes. 
• To assess, and compare, across selected European
countries, the treatment for psychiatric disorders
and to evaluate the unmet need and the quality of
care received. The study will investigate in detail
the use of services across formal and informal care
settings and the variations in care seeking and
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patterns of treatment by levels of need, the quality
of treatment and care received based on standards
to be developed for common mood and anxiety
disorders, the need for treatment and other care,
the use of psychoactive drugs, the duration of treat-
ment (current and in the past 12 months), and the
use of mental healthcare services. 
Sampling and recruitment
The ESEMeD/MHEDEA 2000 study is a cross-sectional
‘in person’ household interview survey based on proba-
bility samples that are representative of the adult,
non-institutionalized population of six European coun-
tries: Belgium, France, Germany, Italy, the Netherlands,
and Spain. In each country, a nationally representative
household sample of individuals aged over 18 years of
age, non-institutionalized (excluding individuals living
in prisons, hospitals, nursing home, hotels, and other
institutions), male or female, with a known household
addresses, and able to understand the language in which
he or she is being assessed (the official language of the
country). Persons who are temporarily away from home
are eligible for the study – they are either interviewed
when they return home (for example, if they are
temporarily hospitalized) or are followed to their tempo-
rary addresses (for example, students). 
A stratified, multi-stage, clustered area probability
sample design without replacement was followed in
each country. Replacement is not allowed to ensure
that every individual has a known probability of selec-
tion. Differences in access to specific population data
dictate slightly different approaches in each country.
The first stage sampling units consists of municipalities.
The largest cities in each country are automatically
included in the sample. Municipalities are stratified by
geography and population size. Selection of municipali-
ties is proportional to size within strata.
The second stage sampling units are persons selected
from these municipalities. In countries where a person-
al registry was available, such as Belgium, Germany
and Italy, it is used as the sampling frame for the selec-
tion of subjects. In the Netherlands and Spain, the
addresses are selected first and the subjects are selected
in a subsequent step. In France, a telephone directory
is used as the sampling frame. Second stage units are
also proportional to population size and selected using
a random start.
About 22,000 individuals are expected to provide a
complete and valid interview. This will assure sufficient
precision for most cross-country comparisons. The
study has been specifically designed to be sufficiently
powerful to estimate confidently the proportion of indi-
viduals with selected diagnoses who do not receive
necessary treatment. For instance, in major depression
we expect this to happen in approximately a quarter of
those with 12-month prevalence.
Survey instrument
The Composite International Diagnostic Interview
(CIDI)
The CIDI (Composite International Diagnostic
Interview) (WHO, 1990) is a comprehensive, fully
structured diagnostic interview for the assessment of
mental disorders. It provides, by means of computerized
algorithms, lifetime and current (12 months and one
month previous to the interview) diagnoses according to
accepted criteria such as the International Classification
of Diseases (ICD-10) and the Diagnostic and Statistical
Manual for Mental Disorders (DSM-IV) (American
Society of Psychiatry, 1994; World Health Organization,
1993). During the CIDI interview, respondents are
asked questions about symptoms related to mental disor-
ders. If enough symptoms are endorsed, and these
symptoms occur in a pattern that suggests a diagnosis
might be present, respondents are asked about the onset
and the recency of the particular cluster of symptoms
that they have endorsed. The paper-and-pencil version
of the CIDI has been shown to be reliable and valid
(Wittchen, Robins, Cottler, Sartorius, Burke and Regier,
1991; Wittchen, 1994).
For the ESEMeD/MHEDEA 2000 study, a new
version of the instrument, the CIDI 2000, was devel-
oped and adapted by the Coordinating Committee of
the WHO-WMH2000 Initiative. This version is
longer and it is computerized to facilitate its adminis-
tration (for instance, it allows using different
itineraries or different proportions of respondents
answering each questionnaire section in order to
maximize the information collected per time unit).
The CIDI 2000 includes fully structured questions on
presence, persistence and intensity of clusters of
psychiatric symptoms followed by probes for age
of onset and lifetime course. The screening section
(the Life-Time Psychiatric Screening Instrument) is
located at the beginning of the questionnaire and
is administered to all the respondents. All subjects
responding positively to a screening question are
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eligible to complete the corresponding CIDI section,
although some exceptions apply. 
The CIDI 2000 also gathers information on risk
factors, symptoms, disability and quality of life, use of
services, and use of medication (see Table 1).
Information on risk factors includes: family history,
stressful emotional experiences, life events, childhood
disorders, personality, spouse relationship, sexual life,
religion, age, gender, ethnicity and social class.
The CIDI 2000 also incorporates measures of the
severity of depression and anxiety disorders. These
measures are based on modifications of standardized
instruments (for example, the short version of the
Hamilton Scale for depression (Hamilton, 1960) or
the short version of the Hamilton Scale for anxiety
disorders (Hamilton, 1959)). Also embedded in the
CIDI 2000 computerized questionnaire are sections
that assess dimensions of health-related quality of life
as measured by the WHO Disablement Assessment
Schedule II (WHO-DAS-II), the Short Form SF-12
Health Survey (SF-12 ) (Ware, Kosinski and Keller,
1995) and the EuroQol 5D (EQ-5D) (The EuroQol
Group, 1990). A set of questions about the burden
imposed by illness on the family is included. The
complete list of standard severity scales used in the
study is shown in Table 2.
A battery of questions regarding use of services has
also been included. Items address whether respondents
sought help from a professional (psychiatrist, psycholo-
gist, general practitioner and other medical doctors)
for specific emotional problems, co-morbid conditions
and general health. The questions also assess the
reasons for use or non-use of health services, whether
the respondents received treatment, the type of treat-
ment (name of medication and dose), the duration and
intensity of care by type of provider and clinical
setting, and barriers to care. While these detailed ques-
tions focus mainly on the prior 12 months, we have
also included more basic questions about timing and
receipt of services over the continuum of lifetime
symptoms. Also included is a set of questions about
whether respondents have been under the care of a
doctor or have received treatment for a standard list of
chronic physical health conditions (such as asthma,
diabetes or hypertension, among others).
The CIDI 2000 was first produced in English and it
underwent a rigorous process of adaptation in order to
obtain conceptually and cross-culturally comparable
versions in each of the target countries/languages. This
process included forward and backward translations,
review by expert panels, pre-testing using cognitive
interview and debriefing techniques and the interven-
tion of focus groups.
Survery procedures
Eligible individuals are asked for their informed
consent to perform a face-to-face interview. The inter-
view takes place in the respondent’s home and requires
an average of less than 90 minutes to complete.
Questions are administered by a trained lay interviewer
using computer-assisted personal interviewing (CAPI)
that has been programmed centrally using the Blaise
software system. The Blaise program is an interviewing
application developed by Statistics Netherlands
(1999), which guides the interviewer through the
respondent selection process, delivers the questions,
and directs the interviewer through the questioning
sequence. 
A survey firm in each country has been contracted
to undertake the survey fieldwork. A detailed descrip-
tion of work was negotiated with each survey firm to
ensure standardization between countries and specifi-
cally to document all scientific and administration
elements that could affect comparability of data. All
interviewers have received the same training and
adhere to the same protocol regarding contacts and
interview administration. The trainers of the inter-
viewers attended a one-week training course, carried
out by WHO-certified trainers. A pre-test phase was
carried out in each country participating in the project.
This used a convenience sample of 50 respondents age
18 or older and provided the opportunity to evaluate
the survey procedures on a small scale and to make
further adjustments of the computerized version of the
CIDI 2000.
Clinical reappraisal
After the main (CIDI) interview, a clinical reappraisal
study is being carried out with 600 respondents. The
study aims at comparing the CIDI diagnoses obtained
by the lay interviewer with those obtained by the reap-
praisal clinician administering the Axis I Structured
Clinical Interview for DSM-IV (SCID), a semi-
structured interview that has been found reliable in
community surveys (First, Spitzer and Williams, 1995).
The clinical reappraisal interviewers were trained
centrally to assure uniform calibration in the evalua-
tion. It included an initial training of more than 40
IJMPR 11(2)_CRC(REV'd)  16/7/02  1:28 PM  Page 59
ESEMeD/MHEDEA 2000 Investigators60
Table 1. List of sections of the Composite International Diagnostic Interview (CIDI) 2000
Section Number of items Administration time (minutes) † 
Screening 51 12.21
Depression 232 2.51
Dysthymia screen 86 2.48
* Mania -
* Irritable depression -
Panic disorder 165 2.41
Specific phobia 163 4.58
Social phobia 114 7.3
Agoraphobia 105 5.64
Generalized anxiety disorder 180 2.4
Post-traumatic stress disorder 813 9.89
* Tobacco -
Substance use 386 4.96
Personality, part 1 55 -
Obsessive-compulsive disorder 155 2.58
Eating disorder 86 0.33
Premenstrual dyndrome 72 2.38
Psychosis screen 21 2.21
Suicidality 40 0.42
Personality, part 2 20 -
Pharmacoepidemiology 1.98
Services 245 1
Chronic conditions 184 8.3
30-Day functioning 59 7.51
30-Day symptoms 26 -
Family burden 87 2.68
Personality disorders screen 34 -




* Social networks -




Conduct disorder 61 2.73
Oppositional-defiant disorder 68 1.51
Separation anxiety disorder 111 2.25
‡ Dementia -
Health state 6 1.48
Administered to:
  All respondents         Only respondents with positive screening         Respondents with screen positive + a random 
subgroup of screen negatives
* Sections not included in the ESEMeD questionnaire.   
† Median values, based on 823 initial interviews.
‡ For documenting Dementia, a paper version adaptation of the MMSE is used instead.
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hours, plus group videotaped interviews with a WHO-
certified trainer and up to five tape-recorded
supervised interviews. 
The SCID was adapted to the specific purpose of the
clinical reappraisal study. Only the sections covered in
the main CIDI interview have been maintained (specif-
ically, anxiety, depressive and substance-use disorders)
and only 12-month prevalence is assessed. The purpose
of the clinical reappraisal interview is to allow clini-
cians to probe and clinically evaluate responses already
obtained by lay interviewers using the CIDI, so the
results of positively answered screening questions in the
CIDI interview are incorporated into the SCID ques-
tionnaire provided to the clinician (CIDI screening
questions refer to lifetime symptoms, whereas SCID
ratings will refer only to the previous 12 months). In
order to increase the test’s ability to evaluate sub-
threshold cases, most of the skip rules embedded in the
original SCID have been deleted. Clinical severity
scales have been incorporated to the SCID and are
interleaved within the modules to ease administration
(for example, the MADRS (Montgomery and Asberg,
MOOD DISORDERS:
Depression:
• Hospital Anxiety and Depression Scale (HADS)
*Irritable Depression:
• Hospital Anxiety and Depression Scale (HADS)
ANXIETY DISORDERS
Panic Disorder:
• Panic Disorder Severity Scale (PDSS) (Shear)
• Sheehan Disability Scale
Generalized Anxiety Disorder:
• Hospital Anxiety and Depression Scale (HADS)
Obsessive-Compulsive Disorder:
• Yale-Brown Obsessive Compulsive Scale (Y-BOCS) – 
separate scales for Obsessions and Compulsions.
OTHER DISORDERS
*Tobacco: 
• Fagerstrom Test for Nicotine Dependence (FTND)
Personality, part 1:
• Zuckerman Personality Scales
Personality, part 2:












• Daytime Sleepiness Scale
• Insomnia Scale
• IBS – Irritable Bowel Syndrome
• Perceived Treatment Efficacy
30-day Symptoms:
• Non-Specific Distress Scale
• Dissociative Experience Scale – Short Form (DES)
Health Status:
• WHO Disablement Assessment Schedule II 
(WHODAS-II)
• EuroQol  (EQ-5D)
• Short Form 12 (SF-12)
OTHER SCALES
Marriage /Steady Partnership:
• Dyadic Adjustment Scale (DAS)
Childhood:
• Family History Research Diagnostic Criteria (RDC) 
interview 
• Parental Bonding Instrument
Table 2. Standard scales included in the Composite International Diagnostic Interview (CIDI) 2000
*Sections not included in the ESEMeD questionnaire.
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1979) for depression or the HAD for generalized anxi-
ety disorder). At the end of the interview, the clinician
will also rate the Global Assessment of Functioning
(GAF) scale, a standard measure of overall clinical
severity used to assess need for treatment (National
Institute of Mental Health, 1976). 
Data management and control
Data are being received, checked and stored at the
project data centre, the Institut Municipal
d’Investigació Mèdica (IMIM), in Barcelona, Spain.
The survey firm in each country is securely transfer-
ring the raw data files to an IMIM server via a secure
Web site and IMIM is transferring information back
using the same site. This site uses the transmission
protocol SSL (Secure Socket Layer) to encrypt data
that flow through the server.
A data quality-control plan has been implemented
with the goal of ensuring that data collection activi-
ties yield the highest quality data possible and are
Figure 1. Conceptual framework of the ESEMeD/MHEDEA 2000 project: relationship between main study variables.
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completed on time. The control procedures are orga-
nized at the local and central levels and are
coordinated by staff at the data centre and by
members of the scientific committee. The data centre
is in charge of monitoring a number of procedures that
are developed with the purpose of ensuring that survey
firms implement data collection procedures according
to survey specifications, that they complete the
reporting requirements, and that interviewers perform
according to the training specifications. A number of
reports are evaluated centrally: weekly production,
sample releases, verification, and monitor contacts.
The duration of the interviews and several survey
variables (for example, the proportion of positive
responses to selected screening questions) is routinely
monitored.
At the local level, the national investigator team is
responsible for
• reviewing the responses to open-ended questions
(to check informal information does not rule out a
clinical diagnose of mental disorders, for instance
because symptoms are due to a physical illness);
and
• verifying at the survey firm headquarters the
contact and the verifications records, the mailing
of the study brochure and letter, and the informed
consent and the contact information files. 
Conceptual model and analysis plan
Figure 1 depicts the conceptual framework of the
ESEMeD/MHEDEA 2000 project, which will govern
the analysis. The central part of the figure illustrates
the relationships between mental disorders (and the
role of duration and severity), the individual’s quality
of life, need for care, and the extent to which this need
is met. Additionally, risk factors, medical conditions
and family support/burden may have a modifying role
in this relationship. Beyond this central part, there are
a number of characteristics that may influence the
previous set of relations in a causal way. 
The analyses will obviously focus on the main
project objectives. Specifically, the prevalence of 15
psychiatric disorders and their co-morbid combina-
tions; the association of disorders with selected risk
factors; the overall health perceptions of persons with
different disorders; and the care-seeking, and the
intensity of service used by persons with different
mental morbidity and disability levels. All the analyses
will be carried out for each country and then between
countries using a pooled sample. Analyses will be
performed between groups of patients, for the condi-
tions of interest to the study, as well as between
individuals with and without these conditions.
Analyses will use design-based estimation methods
that take into consideration the clustering and weight-
ing of the data to compute accurate significant tests. In
addition, adjustment for non-response bias will be
attempted (Kessler, Little and Groves, 1995).
Prevalence of mental disorders and associated risk factors
Estimates of the prevalence and correlates of psychi-
atric disorders will focus on the 12 months prior to the
interview. Focus will be on common disorders (general-
ized anxiety disorder, panic disorder, simple and social
phobia and agoraphobia, and post-traumatic stress
disorder; major depression, dysthymia, and bipolar
disorder; as well as alcohol abuse and dependence, and
drug abuse and dependence). The primary comorbid
combinations of interest will be affective anxiety disor-
ders and substance dependence/abuse. Major risk
factors that will be analysed include personality, as well
as characteristics related to family and sexual behav-
iour, and religion. Appropriate emphasis will be given
to the directionality and the plausibility of a causal
relationship, as well as to the validity limitations of the
measurement of those factors. 
Consequences of mental disorders on quality of life
The goal of this part of the analysis is to examine
components of the quality of life of persons with differ-
ent mental disorders. Those components will be the
standardized global score and dimension-specific scores
of the instruments used (WHO-DAS II, SF-12 and
EQ-5D). First, we are interested in the measurement of
the unique association of mental disorders (that is,
adjusted for the presence of other medical and psychi-
atric conditions) with indicators of disability and
overall health status and perceptions of wellbeing.
Secondly, we will compare the impact of different
mental disorders and groups of disorders with that of
medical conditions and with the absence of any disor-
ders. Finally, the proportion of disability attributable to
mental disorders will be estimated by considering both
the above-mentioned associations and the prevalence
of each particular disorder and group of disorders
examined. We will consider the interaction between
mental and physical disorders. 
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Patterns of health services use for mental disorders and
disability
In this part of the analysis, care seeking, intensity of
service use and appropriateness of care will be examined.
We will take several approaches in order to construct the
need variables, based on the prevalence, persistence and
severity of mental disorders (the impact of different
approaches to the estimation of need will be taken into
account through sensitivity analysis). 
First, we will examine aspects of services use by
number and recency of disorders, with care seeking
(any contact made for a mental health symptom) as
the dependent variable. Another set of analyses will
assess factors associated with the type of provider and
the setting of care. A wide range of mental health
providers and institutions will be considered in addi-
tion to psychologists and psychiatrists. Intensity of care
will also be examined.
A final set of analyses will probe more deeply into the
quality of treatment for selected disorders, including
depression and selected anxiety disorders, considering
both pharmaco-therapy and psychotherapy treatment.
Our approach to these analyses will decompose services
utilization into its two components:
• any visit to a professional for a cluster of symptoms;
and
• service used (medications and visits) among people
who made any contact with services.
All services analyses will emphasize the comparison
across countries with the specific hypothesis that
access to mental healthcare will modify the use of
services. The indicators used to evaluate the level of
access to mental health services in each country partic-
ipating in the study are shown in Table 3.
The ESEMeD/MHEDEA 2000 project will emphasize
the extent to which mental healthcare needs are met
in each of the participating countries. The project will
provide new knowledge that should be useful for future
research, including testing hypotheses about the differ-
ences found across countries in the prevalence of
mental disorders and associated risk factors, the burden
of mental disorders and the use of treatment and care
services for mental health problems.
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